Technology News and Research

RSS

Charles River Laboratories International reports 1.4% decline in first-quarter 2010 net sales

Charles River Laboratories International, Inc. today reported its results for the first quarter of 2010. For the quarter, net sales were $297.3 million, a decline of 1.4% from $301.5 million in the first quarter of 2009. The decrease was net of a foreign currency translation benefit of 3.4%. Higher sales for the Research Models and Services (RMS) segment were offset by lower sales for the Preclinical Services (PCS) segment.

26 Apr 2010

Recent business progress at Penwest Pharmaceuticals

Penwest Pharmaceuticals Co. today sent a letter to its shareholders to provide an update on the Company's recent progress and on corporate governance developments.

24 Apr 2010

JHUSON introduces Text4Baby program to provide parenting tips to new parents

Having a baby is a very exciting time for new parents, with all the preparation and anticipation that comes with it. But how do parents find help and assistance—from prenatal care to parenting tips? Researchers at the Johns Hopkins University School of Nursing have come up with innovative ways to provide parenting tips to new parents of all demographics.

24 Apr 2010

Animal studies demonstrate safety profile of ACT's RPE cell therapy for SMD

Advanced Cell Technology, Inc. announced today that it has completed key animal studies in connection with its Phase I multicenter study using embryonic stem cell derived Retinal Pigment Epithelium (RPE) cells to treat patients with Stargardt's Macular Dystrophy (SMD), for which it filed an Investigational New Drug Application (IND) with the US Food and Drug Administration (FDA) in November. The studies demonstrated an excellent safety profile with no safety signals such as tumors or ectopic tissues.

24 Apr 2010

Trinean launches DropSense96 and DropPlate 16 G for genomic DNA quantification

Only 6 months after the release of its ground-breaking DropSense 96 spectrophotometer, Trinean, pioneer in high throughput analysis of droplets of samples in microfluidic structures, is now launching another device that will set the tone in scientific circles: the DropPlate 16 G. This upgrade of the current microfluid disposable, the DropPlate 16 U, allows researchers to quantify 96 DNA/RNA samples of only 2 microl in less than 5 minutes.

24 Apr 2010

RXi Pharmaceuticals to present data on rxRNA therapeutic platform development at upcoming conferences

RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.

24 Apr 2010

Healthagen announces international agreement with Asklepios

Healthagen - U.S. developer of the iTriage consumer healthcare platform, today announced an international agreement with Asklepios - the largest privately-held hospital system operating in Germany. Asklepios and Healthagen partnered to private label Healthagen's content, and decision support software, introducing Meine Klinik - a German language consumer-based medical technology.

24 Apr 2010

Presidio Pharmaceuticals, Numerate conclude collaboration to discover new compounds targeting HCV

Presidio Pharmaceuticals, Inc., and Numerate, Inc., today announced that they have concluded their two-year collaboration to discover new compounds that target hepatitis C virus (HCV).

24 Apr 2010

New Actellic- 300CS demonstrates effective control of pyrethroid resistant mosquitoes

The Innovative Vector Control Consortium and Syngenta announced today that the latest field trials of the new Actellic- 300CS micro-encapsulated formulation demonstrate effective control of pyrethroid resistant mosquitoes on treated construction materials for more than eight months.

24 Apr 2010

New hopes to improve cancer diagnosis and treatment for children

Motivated clinicians and an Internet connection combined with computers and e-mail access have the power to transform pediatric cancer treatment in the most remote corners of earth, according to a St. Jude investigator writing in a recent issue of The Lancet Oncology.

24 Apr 2010

Continuous flow mechanical circulatory support devices improve outcomes in patients awaiting heart transplants

New data show improved outcomes, better survival rates and lower costs with the use of continuous flow mechanical circulatory support devices in patients awaiting heart transplants. Research will be presented this week during symposia at the International Society for Heart and Lung Transplantation (ISHLT) 30th Annual Meeting and Scientific Session at the Hilton Chicago.

24 Apr 2010

New Zimmer Institute training center opened at TMT facility in Parsippany, New Jersey

Zimmer Holdings, Inc. today announced the opening of a new Zimmer Institute training center at its Trabecular Metal Technology facility in Parsippany, New Jersey. The Zimmer Institute at TMT will be Zimmer's first full-time BioSkills training center outside of the Zimmer Institute's headquarters in Warsaw, Indiana.

24 Apr 2010

New eTransform Initiative to improve healthcare infrastructure in developing countries

The World Bank and Pfizer Inc. today announced they will collaborate to improve the healthcare infrastructure, specifically the supply chain, in developing countries, starting with Africa. The novel public-private collaboration will focus on enhanced use of Information and Communication Technologies' transformative power to improve healthcare delivery.

24 Apr 2010

Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selecting chemotherapy for NSCLC

Moffitt Cancer Center announces steadily growing interest in the ERCC1 Analysis, the first test developed for selecting chemotherapy for Non Small Lung Cancer patients. Each year, more than 200,000 Americans are diagnosed with lung cancer.

24 Apr 2010

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

Cardiola AG announced today that the Company's CE-Marked m.pulse® Muscular CounterPulsation ("MCP")-based system demonstrated "an immediate improvement of cardiac output with non-invasive means" in a patient population of advanced yet stable chronic heart failure. The effects could be shown in 22 patients over three consecutive days.

24 Apr 2010

AFFiRiS' AD02 Alzheimer's vaccine candidate in phase II clinical testing

AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the corresponding phase I study. The company is active in several disease areas and is currently developing a total of twelve prospective products in all stages of the development pipeline up to clinical phase II.

24 Apr 2010

Health IT policy group calls for patient safety oversight program

Modern Healthcare: The federal Health Information Technology Policy Committee is calling for the development of a national program that would monitor patient safety problems in health care IT systems. "The first among the work group's recommendations was a proposal to create 'a national transparent oversight process and information system,' similar to a patient-safety organization, that could receive reports from various sources about patient-safety issues linked to the use of healthcare IT systems."

24 Apr 2010

Broadspire, Medcor partner to provide direct immediate post-injury treatment for employees

Broadspire, a Crawford Company and leading third party administrator of workers compensation claims, liability claims and medical management services, and Medcor, a leading injury triage provider, are partnering to implement services to more effectively direct immediate post-injury treatment for employees.

24 Apr 2010

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

"A year after the emergence of swine flu [H1N1], U.S. health authorities and laboratories say the pandemic illustrated the need for new vaccine production techniques that are faster and more reliable," Agence France-Presse writes in an article that examines the challenges associated with current vaccine development practices and plans for future development.

24 Apr 2010

NDSsi's ZeroWire Duo wireless Full HD video solution receives FDA clearance

NDS Surgical Imaging today announced it has received U.S. Food and Drug Administration 510(k) clearance for ZeroWire Duo, a Class II medical-grade wireless Full HD video solution for minimally-invasive surgery, GI and interventional suites.

24 Apr 2010

Technology News and Research

Charles River Laboratories International reports 1.4% decline in first-quarter 2010 net sales

Recent business progress at Penwest Pharmaceuticals

JHUSON introduces Text4Baby program to provide parenting tips to new parents

Animal studies demonstrate safety profile of ACT's RPE cell therapy for SMD

Trinean launches DropSense96 and DropPlate 16 G for genomic DNA quantification

RXi Pharmaceuticals to present data on rxRNA therapeutic platform development at upcoming conferences

Healthagen announces international agreement with Asklepios

Presidio Pharmaceuticals, Numerate conclude collaboration to discover new compounds targeting HCV

New Actellic- 300CS demonstrates effective control of pyrethroid resistant mosquitoes

New hopes to improve cancer diagnosis and treatment for children

Continuous flow mechanical circulatory support devices improve outcomes in patients awaiting heart transplants

New Zimmer Institute training center opened at TMT facility in Parsippany, New Jersey

New eTransform Initiative to improve healthcare infrastructure in developing countries

Moffitt Cancer Center reports increasing interest in ERCC1 Analysis test for selecting chemotherapy for NSCLC

Cardiola's m.pulse MCP based system improves cardiac function in stable CHF patients

AFFiRiS' AD02 Alzheimer's vaccine candidate in phase II clinical testing

Health IT policy group calls for patient safety oversight program

Broadspire, Medcor partner to provide direct immediate post-injury treatment for employees

News outlets examine H1N1's impact on U.S. vaccine development plans, Mexico's handling of outbreak

NDSsi's ZeroWire Duo wireless Full HD video solution receives FDA clearance

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News